Home > Financial Ratios > BAL PHARMA

BAL PHARMA
Cash Earnings per Share (CEPS)

    Back to All Ratios
COMMUNITY POLL
for BAL PHARMA
Please provide your vote to see the results

BAL PHARMA Last 5 Year Cash Earnings per Share (CEPS) History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
   CEPS(Rs) 7.499.959.60-3.685.86

What is the latest Cash Earnings per Share (CEPS) ratio of BAL PHARMA ?

The latest Cash Earnings per Share (CEPS) ratio of BAL PHARMA is 7.49 based on Mar2023 Consolidated results.
Year Cash Earnings per Share (CEPS)
Mar20237.49
Mar20229.95
Mar20219.60
Mar2020-3.68
Mar20195.86

How is Cash Earnings per Share (CEPS) of BAL PHARMA Trending?

Years Cash Earnings per Share (CEPS) % Change
Mar2023 7.49
-24.72
Mar2022 9.95
3.65
Mar2021 9.6
Positive
Mar2020 -3.68
Negative
Mar2019 5.86 -

Other Financial Ratios of BAL PHARMA


Compare Cash Earnings per Share (CEPS) ratio of peers of BAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAL PHARMA ₹155.8 Cr -1.7% -4.7% 23.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹358,305.0 Cr -1% -7.2% 56.8% Stock Analytics
CIPLA ₹109,709.0 Cr -4.6% -6.2% 49.8% Stock Analytics
DIVIS LABORATORIES ₹100,599.0 Cr -4.1% 1.1% 19.8% Stock Analytics
DR REDDYS LABORATORIES ₹98,073.3 Cr -7.4% -4.8% 22.7% Stock Analytics
ZYDUS LIFESCIENCES ₹97,383.3 Cr -2.9% -3.9% 94.8% Stock Analytics


BAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BAL PHARMA

-1.7%

-4.7%

23.7%

SENSEX

-3%

-2.5%

17.3%


You may also like the below Video Courses